RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
14.81
+0.25 (1.72%)
Apr 29, 2025, 2:07 PM EDT - Market open
RxSight Market Cap
RxSight has a market cap or net worth of $601.59 million as of April 29, 2025. Its market cap has decreased by -70.59% in one year.
Market Cap
601.59M
Enterprise Value
366.50M
1-Year Change
-70.59%
Ranking
Category
Stock Price
$14.81
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has increased from $424.33M to $601.59M, an increase of 41.77%. That is a compound annual growth rate of 9.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 591.43M | -57.32% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |